Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net loss	$ (156,324)	$ (13,639)
Cash flows due to changes in operating assets and liabilities	(135,303)	(57,763)
Net cash used in operating activities	(291,816)	(25,248)
Cash flows from investing activities:
Purchase of furniture, equipment and leasehold improvements, net	(10,252)	(2,799)
Net cash used in investing activities	(10,252)	(2,799)
Allocable to non-controlling interest in Consolidated Funds:
Net cash provided by financing activities	60,781	17,382
Ares Management L.P
Cash flows from operating activities:
Adjustments to reconcile net loss to net cash used in operating activities	(18,522)	(3,907)
Cash flows from financing activities:
Proceeds from credit facility	165,000	127,000
Proceeds from term notes	17,600	0
Repayments of credit facility	0	(45,000)
Distributions	(68,595)	(44,051)
Preferred equity distributions	(5,425)	0
Repurchase of treasury stock	(3,913)	0
Stock option exercise	1,036	0
Excess tax benefit related to stock option exercise	81	0
Other financing activities	646	(362)
Allocable to non-controlling interest in Consolidated Funds:
Effect of exchange rate changes	2,415	(884)
Net change in cash and cash equivalents	(238,872)	(11,549)
Cash and cash equivalents, beginning of period	342,861	121,483
Cash and cash equivalents, end of period	103,989	109,934
Consolidated Funds
Cash flows from operating activities:
Adjustments to reconcile net loss to net cash used in operating activities	(81,753)	34,748
Cash flows due to changes in operating assets and liabilities	100,086	15,313
Allocable to non-controlling interest in Consolidated Funds:
Contributions from non-controlling interests in Consolidated Funds	23,378	47,366
Distributions to non-controlling interests in Consolidated Funds	(7,822)	(23,230)
Borrowings under loan obligations by Consolidated Funds	505,714	750
Repayments under loan obligations by Consolidated Funds	(566,919)	$ (45,091)
Cash and cash equivalents, beginning of period	455,280
Cash and cash equivalents, end of period	$ 346,312